Učitavanje...
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
A formulation of aflibercept for intravitreal injection (Eylea) is approved for the treatment of patients with exudative age-related macular degeneration (AMD). Aflibercept has a significantly higher affinity for Vascular endothelial growth factor (VEGF)-A compared with other monoclonal anti-VEGF an...
Spremljeno u:
| Izdano u: | Drugs Aging |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607716/ https://ncbi.nlm.nih.gov/pubmed/26442858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-015-0300-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|